Dr. Frances Shepherd CV - (NCRI) is

histology on outcomes in non-small cell lung cancer: a pooled analysis if five randomized trials.
Ann Oncol. 2010; 10: 2023-8.
86. Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P
Intenational Staging Committee including Shepherd FA, and Participating Institutions.
The International Association for the Study of Lung Cancer Staging Project. Zhongguo
Fei Ai Za Zhi. J Thorac Oncol 2010; 13: 9-18.
87. NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A, Burdett S, Higgins JP,
Johnson DH, Le Chevalier T, Le Pechoux C, Parmar MK, Pignon JP, Souhami RL, Stephens RJ,
Stewart LA, Tierney JF, Tribodet H, Shepherd FA, van Meerbeeck J. Adjuvant chemotherapy,
with or without postoperative radiotheraopy, in operable non-small cell lung cancer: two metaanalyses
of individual patient date. Lancet. 2010; 375: 1267-77.
88. Goodwin R, Ding K, Seymour L, LeMaitre A, Arnold A, Shepherd FA, Dediu M, Ciuleanu T,
Fenton D, Zukin M, Walde D, Laberge F, Vincent M, Ellis PM, Laurie SA, NCIC Clinical Trials
Group Study BR.24. Group. Ann Oncol. 2010; 21: 2220-07.
89. Wheatley-Price P, Le Maitre A, Ding K, Leighl N, Hirsh V, Seymour L, Bezjak A, Shepherd
FA. The influence of sex on efficacy, adverse events, quality of life and delivery of treatment in
NCIC Clinical Trials Group non-small cell lung cancer chemotherapy trials. J Thorac Onc. 2010;
5: 640-8.
90. Gridelli C, Ardizzoni A, Douillard JY, Hanna N, Manegold C, Perrone F, Pirker R, Rosell R,
Shepherd FA, De Petris L, Di Maio M, de Marinis F. Recent issues in first-line treatment of
advanced non-small cell lung cancer: Results of an International Expert Panel Meeting of the
Italian Association of Thoracic Oncology. Lung Cancer. 2010; 68: 319-31
91. Lo C, Zimmerman C, Rydall A, Walsh A, Jones JM, Moore MJ, Shepherd FA, Gagliese L,
Rodin G. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal
and lung cancer. J Clin Oncol. 2010; 28: 3084-9.
92. Brenner DR, Hung RJ, Tsao MS, Shepherd FA, Johnston MR, Narod S, Rubenstein W,
McLaughlin JR. Lung cancer risk in never-smokers: a population-based-case-control study of
epidemiologic risk factors. BMC Cancer 2010; 10: 285.
93. Booth CM, Shepherd FA, Peng Y, Darling GE, Li G, Kong W, Mackillop WJ. Adoption of
adjuvant chemotherapy for non-small cell lung cancer: a population-based outcomes study. J Clin
Oncol. 2010 20; 28: 3472-8.
94. Leighl NB, Raez LE. Besse B, rosen PJ, Barlesi F, Massarelli E, Gabrail N, Hart LL, Albain KS,
Berkowitz L, Melnyk O, Shepherd FA, Sternas L, Ackerman J, Shun Z, Miller VA, Herbst RS. A
multicenter, phase 2 study of vascular endothelial growth factor trap (afibercept) in platinum- and
erlotinib-resistant adenocarcinoma of the lung. J Thorac Oncol. 2010; 5: 1054-9.
95. Shepherd FA, Mallarkey G. Highlights of the 2 nd Eurpoean Lung Cancer Conference. Editorial:
Therapeutic Advances in Med Oncol 2010; 2: 297-299.
96. Wei Y, Tong J, Taylor P, Strumpf D, Ignatchenko V, Pham NA, Yanagawa N, Liu G, Jurisica I,
Shepherd FA, Tsao MS, Kislinger T, Moran MF. Primary Tumor Xenografts of Human Lung
Adeno and Squamous Cell Carcinoma Express Distinct Proteomic Signatures. J Proteome Res. 2010;
10: 161-74
97. Giuliani M, Sun A, Bezjak A, Ma C, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ.
Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma.
Cancer. 2010; 116: 5694-6.
98. Zhu CQ, Strumpf D, Li CY, Li Q, Liu N, Der S, Shepherd FA, Tsao MS, Jurisica I. prognostic gene
expression signature for squamous cell carcinoma of the lung. Clin Cancer Res. 2010; 16: 5038-47.
99. Brade A, Bezjak A, Macrae R, Laurie S, Sun A, Cho J, Leighl N, Pearson S, Southwood B, Wang L,
McGill S, Iscoe N, Shepherd FA. Phase I Trial of Radiation with Concurrent and Consolidation
Pemetrexed and Cisplatin in Patients with Unresectable Stage IIIA/B Non-Small Cell Lung Cancer.
Int J Radiat Oncol Bio Phys. 2010; 79: 1395-401.
12